Search filters

List of works by Samantha Pozzi

5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells.

scientific article

A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up.

scientific article

A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function

scientific article

A simple and safe nomogram for the management of oral anticoagulation prior to minor surgery

scientific article published in April 2003

ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.

scientific article published on 5 January 2009

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition.

scientific article published on 25 January 2010

Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients.

scientific article

Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients

scientific article published on 26 October 2016

Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease

scientific article

Activity of BKM120 and BEZ235 against Lymphoma Cells.

scientific article published on 18 October 2015

Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma

scientific article published in May 2009

Antimyeloma Activity of a Multitargeted Kinase Inhibitor, AT9283, via Potent Aurora Kinase and STAT3 Inhibition Either Alone or in Combination with Lenalidomide ⬇️

scientific article published on March 23, 2011

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.

scientific article published on 21 July 2016

Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts.

scientific article published on February 2005

Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.

scientific article published on January 2007

Bisphosphonates and Atypical Femoral Fractures ⬇️

scientific article published on September 9, 2010

Bisphosphonates-associated osteonecrosis of the jaw: A long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over time.

scientific article published in December 2009

Cell-Penetrating CaCO₃ Nanocrystals for Improved Transport of NVP-BEZ235 across Membrane Barrier in T-Cell Lymphoma

scientific article

Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy.

scientific article

Dialysis-dependent renal failure at diagnosis continues to be associated with very poor outcome in multiple myeloma - response to Murphyet al

scientific article published on 06 March 2014

Fatty acid synthase is a novel therapeutic target in multiple myeloma

scientific article published on 10 April 2008

In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma.

scientific article published on 17 January 2013

Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients

scientific article published on 01 May 2007

MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts.

scientific article

Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era

scientific article

Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas

scientific article published on 08 February 2013

NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy.

scientific article published on 25 August 2012

Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients

scientific article published on 28 October 2016

Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice

scientific article

Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma

scientific article published on 8 January 2009

Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story.

scientific article published on 17 November 2009

Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study.

scientific article published on November 2007

Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study.

scientific article

Role of thalidomide in previously untreated patients with multiple myeloma.

scientific article published on October 2008

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi

scientific article published on 8 February 2016

Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study.

scientific article

Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.

scientific article published on 11 February 2008

Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis.

scientific article published on 27 July 2013

The Role of Bisphosphonates in Multiple Myeloma: Mechanisms, Side Effects, and the Future ⬇️

scientific article published on April 14, 2011

The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines.

scientific article

The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines

scientific article published on 12 August 2016

The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo

scientific article

The potential of pralatrexate as a treatment of peripheral T-cell lymphoma.

scientific article published on 25 March 2014

Paulina is supported by:

About Paulina

Help